Published in Nat New Biol on March 28, 1973
vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J (1989) 3.67
Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1975) 3.28
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Deletion mapping of moloney type C virus: polypeptide and nucleic acid expression in different transforming virus isolates. J Virol (1976) 2.39
Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol (1979) 1.90
Comparative study of different isolates of murine sarcoma virus. J Virol (1979) 1.80
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37
Mitosis is required for production of murine leukemia virus and structural proteins during de novo infection. J Virol (1975) 1.08
Baboon virus isolate M-7 with properties similar to feline virus RD-114. J Virol (1974) 1.06
Phosphorylation and nucleic acid binding properties of m1 Moloney murine sarcoma virus-specific pP60gag. J Virol (1977) 1.05
Characterization of Gazdar murine sarcoma virus by nucleic acid hybridization and analysis of viral expression in cells. J Virol (1977) 0.93
Effect of helper virus on the number of murine sarcoma virus DNA copies in infected mammalian cells. J Virol (1977) 0.93
Molecular mechanisms involved in the differential expression of gag gene products by clonal isolates of a primate sarcoma virus. J Virol (1978) 0.87
Lack of focus formation of S+L- mink cells by the ecotropic murine leukemia viral genome. J Virol (1980) 0.75
Mechanism of activation of a human oncogene. Nature (1982) 12.09
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer (1970) 5.48
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
The p21 ras C-terminus is required for transformation and membrane association. Nature (1984) 4.43
Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature (1980) 4.43
Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. Proc Natl Acad Sci U S A (1979) 4.34
An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C, and the feline--primate viruses RD-114/CCC/M-7. Virology (1975) 4.31
Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus. EMBO J (1984) 4.28
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science (1981) 4.27
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses (1987) 3.67
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell (1992) 3.30
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29
Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1975) 3.28
Quantitative infectivity assay for HIV-1 and-2. Nature (1988) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.86
Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol (1974) 2.84
Mutational analysis of a ras catalytic domain. Mol Cell Biol (1986) 2.76
Isolation of RD-114-like oncornavirus from a cat cell line. J Virol (1973) 2.61
Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells. Proc Natl Acad Sci U S A (1980) 2.45
Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci U S A (1983) 2.44
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Phenotypic mixing between N- and B-tropic murine leukemia viruses: infectious particles with dual sensitivity to Fv-1 restriction. Cell (1976) 2.34
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A (1987) 2.25
Murine sarcoma virus (Harvey): characteristics of focus formation in mouse embryo cell cultures, and virus production by hamster tumor cells. Int J Cancer (1968) 2.24
Further evidence for deletion of envelope glycoprotein (gp69/71) sequences in formation of Moloney-murine sarcoma virus. J Gen Virol (1978) 2.22
A replication-defective variant of Moloney murine leukemia virus. I. Biological characterization. J Virol (1978) 2.09
Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology (1982) 2.02
Suppression of c-ras transformation by GTPase-activating protein. Nature (1990) 1.96
Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst (1969) 1.96
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol (1988) 1.95
Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle. Cell (1977) 1.95
Mutant of B-tropic murine leukemia virus synthesizing an altered polymerase molecule. J Virol (1979) 1.90
Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes. Mol Cell Biol (1985) 1.85
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science (1968) 1.73
Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl Acad Sci U S A (1989) 1.69
Murine sarcoma virus pseudotypes acquire a determinant specifying N or B tropism from leukaemia virus during rescue. Nature (1975) 1.68
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol (1977) 1.65
Dual susceptibility of A 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-1 gene. Int J Cancer (1974) 1.65
Inhibitors of glycosylation reverse retroviral interference. Virology (1982) 1.64
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
Saccharomyces cerevisiae synthesizes proteins related to the p21 gene product of ras genes found in mammals. Mol Cell Biol (1984) 1.53
Donation of N- or B-tropic phenotype to NB-tropic murine leukemia virus during mixed infections. J Virol (1977) 1.52
Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol (1987) 1.49
Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol (1972) 1.44
Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology (1978) 1.42
Presence of sarcoma genome in a "non-infectious" mammalian virus. Nat New Biol (1971) 1.39
The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J (2000) 1.38
Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24. EMBO J (1992) 1.38
A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37
Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol (1977) 1.37
Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol (1971) 1.32
Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science (1987) 1.30
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis. J Gen Virol (1971) 1.29
Murine sarcoma virus defectiveness. Viral polymerase expression murine and nonmurine host cells transformed by S+L-type murine sarcoma virus. Virology (1975) 1.28
Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus. Virology (1974) 1.28
Molecular relatedness of mammalian RNA tumor viruses as determined by DNA hybridization. Science (1973) 1.28
Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses (1987) 1.26
Elimination of the sarcoma genome from murine sarcoma virus transformed cat cells. Science (1976) 1.26
Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science (1985) 1.26
Rescue and transmission of a replication-defective variant of moloney murine leukemia virus. J Virol (1979) 1.25
Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology (1972) 1.25
Mechanistic aspects of signaling through Ras in NIH 3T3 cells. Science (1992) 1.24
Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1980) 1.24
Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1. Science (1990) 1.21
Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology (1976) 1.19
Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus. Science (1972) 1.18
Productive infection and morphologic alteration of human cells by a modified sarcoma virus. J Natl Cancer Inst (1970) 1.17
Efficient release of murine xenotropic oncornavirus after murine leukemia virus infection of mouse cells. Virology (1975) 1.16
Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane-anchoring domains. EMBO J (1985) 1.16
Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J Virol (1991) 1.15
Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1987) 1.14
Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks. Science (1978) 1.14
Radiation leukemia virus: quantitative tissue culture assay. Science (1969) 1.13
Two active forms of RD-114 virus DNA polymerase in infected cells. Cell (1975) 1.13
The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH. Mol Cell Biol (1991) 1.13
Viral infection across species barriers: reversible alteration of murine sarcoma virus for growth in cat cells. Science (1969) 1.13
Use of an established cat cell line for investigation and quantitation of feline oncornaviruses. J Natl Cancer Inst (1972) 1.13